Tintina responded this May and DEQ issued a third deficiency letter
with a response from Tintina in July.
In January 2017, the company had also received a deficiency letter
from Nasdaq regarding its non-compliance with Nasdaq Listing Rule 5620(a) for its failure to hold an annual meeting of stockholders no later than December 31, 2016.
RiT Technologies (NASDAQ: RITT) said it has received a NASDAQ staff deficiency letter
, stating that the company fails to comply with the requirement to maintain a minimum bid price of USD1 per its shares.
NYSE: IEC) said that it has received a deficiency letter
from the NYSE MKT LLC indicating that IEC has failed to file its quarterly report on Form 10-Q for the quarter ended December 26, 2014 by the requisite deadline of the Securities and Exchange Commission.
International Resource News-September 27, 2011--Euro Tech Holdings Company Limited receives deficiency letter
from NASDAQ OMX(C)1994-2011 ENPublishing - http://www.
Minneapolis MN), which makes medical products to treat urological disorders, said it received a deficiency letter
from the Nasdaq Global Market.
The goals for the current user fee program are dominated by "cycle" goals, instructing reviewers, for instance, to take a "first action" on a PMA review with a major deficiency letter
within 150 days or a "second or later action" within 100 days on an expedited PMA.
Pyramid had previously received a deficiency letter
from Nasdaq advising that, as a result of Scott Barnum's appointment as CEO and president, and his departure from the audit committee, Pyramid was not in compliance with rules that require a listed issuer to have at least three independent members on its audit committee.
The examination has several possible outcomes: OCIE will notify the adviser that it found no violations, it will send the adviser a deficiency letter
outlining violations and requesting corrective action or refer the adviser to the SEC Division of Enforcement for further investigation.
1) If the application is incomplete in any respect, the agency must send a deficiency letter
within that 30-day period, requesting the missing materials or information.
OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today reported it has received a major deficiency letter
from the United States Food and Drug Administration (FDA) regarding the FDA's review of the dermaPACE([R]) Premarket Approval Application (PMA) for the treatment of diabetic foot ulcers.
M2 EQUITYBITES-April 25, 2016-RiT Technologies gets 3rd NASDAQ deficiency letter